Intel ends its $5.4B deal to buy Israeli company Tower Semiconductor after failing to win Chinese regulatory approval; Intel announced the deal in February 2022
- Deal for Tower Semiconductor needed Chinese antitrust approval — Intel Corp. walked away from its attempt …
Context & Ripple Effects
Intel’s proposed purchase of Tower began as a $5.4B agreement announced in February 2022, positioning the Israeli contract chipmaker as a target of Intel’s expansion effort. The failed approval process ends that route rather than merely delaying it.
The companies later retained an industrial connection through Tower’s planned $300M investment in Intel’s New Mexico factory, indicating that a collapsed merger need not eliminate narrower manufacturing cooperation.
First-order effects
- Intel loses the planned acquisition of Tower and must pursue its manufacturing ambitions without bringing Tower’s business under common ownership.
- Tower remains independent after Chinese antitrust approval was not secured, while both companies avoid the integration required by the proposed deal.
Second-order effects
- Intel and Tower can shift from a full merger to targeted commercial arrangements, as the subsequent New Mexico investment illustrates, but those arrangements offer less control than ownership.
- Prospective cross-border chip deals now face a clearer execution risk: regulatory clearance can determine whether a signed transaction reaches closing.
Third-order effects
- If similar outcomes persist, semiconductor companies may place more value on partnerships, investments, and capacity agreements that do not require a full change of control.
- The episode points to regulatory approval becoming a more consequential constraint on industry consolidation, potentially reshaping how firms sequence and structure international transactions.
The trend: Semiconductor expansion is increasingly being pursued through flexible manufacturing partnerships alongside acquisitions whose completion depends on cross-border regulatory clearance.